Andreas Castan

Andreas Castan, a seasoned expert in bioprocessing at Cytiva, explores the nuances of continuous manufacturing. He challenges the notion that continuous processes automatically deliver productivity gains, revealing that operational complexities and media costs can offset savings. Regulatory hurdles remain despite FDA backing, stressing the need for strong QA measures. Andreas emphasizes strategic timing for adopting continuous methods and warns against blindly embracing technology. He advocates for tailored solutions, focusing on robustness and understanding production bottlenecks.